| methylprednisolone oral / Generic mfg. |
NCT06468007: Comparative Effects of Methylprednisolone and Prednisolone on the Risk of Acute Decompensated Heart Failure - An Emulated Target Trial |
|
|
| Completed | N/A | 12000 | NA | Methylprednisolone Tablet, Prednisolone Tablet | Diakonhjemmet Hospital | Heart Failure; With Decompensation | 08/17 | 12/17 | | |
NCT00971893: A Study To Assess The Safety And Effectiveness Of Medrol® In Acute Asthma In Indian Patients |
|
|
| Withdrawn | N/A | 0 | NA | Oral Methylprednisolone Tablets | Pfizer | Asthma | 04/10 | 04/10 | | |
NCT00929981: A Study To Assess Safety And Effectiveness Of Medrol In Contact Dermatitis In Indian Patients |
|
|
| Completed | N/A | 80 | RoW | Tablet Methylprednisolone (4 or 16 mg) | Pfizer | Dermatitis, Contact | 09/10 | 09/10 | | |
NODAT, NCT02095418: Comparison of New-onset Diabetes After Transplantation Between Two Steroid Withdrawal Group With CellCept |
|
|
| Unknown status | N/A | 152 | RoW | Mycophenolate mofetil, Corticosteroids, CellCept, Methylon, Corticosteroids, Mycophenolate mofetil, Methylon, CellCept | Samsung Medical Center | Diabetes | 02/18 | 02/18 | | |
ChiCTR-INR-17011495: Canceled by the investigator The efficacy and safety of metformin hydrochloride combined with atorvastatin in the treatment of primary mild to moderate systemic sy |
|
|
| Recruiting | N/A | 90 | | The level of SELSNA-SLEDAI was evaluated at week 4, week 12 and week 24, the BILAG table, the SLE lesion index, and the SLE damage index were measured at 4 weeks, 12 weeks and 24 weeks. The levels of Th17, Treg and Th17 / Treg were measured. ;Leflunomide tablets 10m, 1 times / day, orally. The SELSNA-SLEDAI score table, BILAG worksheet, SLE damage index score were assessed at week 4, week 12 and week 24, and serum Th17, Treg and Th17 / Treg ratios were measured. ;0 weeks to give prednisone acetate tablets 0.5-1mg / kg.d (or patients can choose to take the same dose of methylprednisolone tablets), 4 weeks after the beginning of the dose by 2 weeks to reduce the regular dose of 10% Reduction to prednisone acetate tablets 10mg / day to maintain. ;All patients without contraindications plus hydroxychloroquine tablets 0.2,2 / day, orally; and according to the condition plus calcium (800-1200mg / day), vitamin D (200-800IU / day) and other treatment. | The First Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology; The First Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology, Self-raised | Primary mild to moderate systemic systemic lupus erythematosus | | | | |
| Completed | N/A | 56 | | Methylprednisolone 16mg Tablets (Zhejiang Xianju) ;Methylprednisolone 16mg Tablets (Zhejiang Xianju) ;Methylprednisolone 16mg Tablets (Pfizer) ;Methylprednisolone 16mg Tablets (Pfizer) | People's Hospital of Deyang City; People's Hospital of Deyang City, Xianju Pharmaceutical (Zhejiang) Co., Ltd | symptomatic treatment with glucocorticoid | | | | |
NCT04596046: Could Intralesional Steroid be the Novel Treatment for Granulomatous Mastitis? |
|
|
| Completed | N/A | 36 | RoW | steroid injecting | Gaziosmanpasa Taksim Research and Education Hospital | Granulomatous Mastitis | 06/20 | 07/20 | | |
NCT01560052: Therapeutic Evaluation of Steroids in IgA Nephropathy Global Study (TESTING Low Dose Study) |
|
|
| Completed | N/A | 503 | Canada, RoW | methylprednisolone, Medrol, Placebo | The George Institute, Peking University First Hospital | IgA Glomerulonephritis | 07/21 | 07/21 | | |
NCT05990894: Steroid for Treatment of Acute/Subacute Severe Cerebral Venous Thrombosis. |
|
|
| Completed | N/A | 248 | RoW | Methylprednisolone | Xuanwu Hospital, Beijing | Cerebral Venous Thrombosis | 12/21 | 12/21 | | |
NCT06044558: Effect of Azole/Echinocandin Use on Tacrolimus Pharmacokinetics |
|
|
| Completed | N/A | 507 | RoW | Combined with voriconazole, tacrolimus, methylprednisolone sodium succinate, mycophenolate sodium, Combined with caspofungin, Tacrolimus-alone treatment | LI YAN | Kidney Transplant Patients | 01/23 | 06/23 | | |
NCT03856229: Short-term Steroid Therapy in Patients With P. Jirovecii Pneumonia Due to HIV / AIDS |
|
|
| Enrolling by invitation | N/A | 196 | RoW | Conventional steroid regimen, CoSt, Shortened steroid regimen, SSt | Centro de Investigación en. Enfermedades Infecciosas, Mexico | Pneumocystis, HIV/AIDS, Steroid | 10/24 | 10/25 | | |
NCT06198894: Steroid-eluting Sinus Stent for Chronic Rhinosinusitis Patients With Uncontrolled Postoperative Symptoms |
|
|
| Recruiting | N/A | 96 | RoW | steroid-eluting sinus stent implant, BISORB bioabsorbable steroid-eluting sinus stent, Systemic glucocorticoids, Medrol, saline irrigations, 0.9% sodium chloride solution, Placebo, Systemic glucocorticoid placebo, sham procedure, In-office bilateral sham procedure of stent placement | Zheng Liu | Chronic Sinusitis | 01/26 | 04/26 | | |
NCT05842681: Azithromycin in the Management of Patients With Acute Exacerbation of Idiopathic Pulmonary Fibrosis |
|
|
| Not yet recruiting | N/A | 30 | RoW | Azithromycin, azithromycin 500 mg oral tablet, Methylprednisolone, methylprednisolone 500 mg | Assiut University | Idiopathic Pulmonary Fibrosis | 03/24 | 06/24 | | |
ChiCTR2300075076: The effect of combined low-dose methylprednisolone on neurological function and hemodynamics in patients with acute cerebral infarction combined with rheumatoid arthriti |
|
|
| Not yet recruiting | N/A | 100 | | oral aspirin tablets (100mg once a day), Clopidogrel (75mg once a day), Atorvastatin calcium tablets (20mg once a day); ;Oral administration of methylprednisolone tablets (4mg once per day) on the basis of the control group | Xi'an Fifth Hospital; Xi'an Fifth Hospital, Scientific Research Project of Shaanxi Administration of Traditional Chinese Medicine | Cerebrovascular disease | | | | |
ChiCTR1900021199: Mycophenolate Plus Concomitant Steroids versus Orbital Radiotherapy Plus Concomitant Steroids in the treatment of intractable Graves’ ophthalmopathy: a randomised, controlled multicentre trial |
|
|
| Recruiting | N/A | 96 | | oral steroid combined with mycophenolate, Oral methylprednisolone (0.4 mg / kg, for 4 weeks, gradually reduced to a maintenance dose of 4 mg qd) and oral mycophenolate mofetil (500 mg bid) for 24 weeks ;oral steroid combined with orbital radiotherapy | Sun Yat-sen Memorial Hospital, Sun Yat-Sen University; Sun Yat-sen Memorial Hospital, Sun Yat-Sen University, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University | Intractable Graves’ ophthalmopathy | | | | |
